Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Department of Epidemiology and Biostatistics, Institute for Global Health Sciences, University of California San Francisco, USA.
AIDS. 2021 Mar 15;35(4):529-542. doi: 10.1097/QAD.0000000000002757.
Iran, a country in the Middle East and North Africa (MENA) region, has been actively involved in the fight against HIV/AIDS over the past three decades. The unique features of the HIV epidemic in Iran are reflected by the modes of transmission and its recent changes to improve management and prevention programs. In this review, we recount the initial onset and subsequent spread of HIV infection in Iran, beginning with the first case diagnosed to the ongoing responses and most recent achievements in controlling this epidemic. Although in the MENA region, Iran is one of the pioneers in implementing pertinent policies including harm reduction services to decrease HIV incidence, drug injection still continues to be the major risk of infection. In line with other nations, the programs in Iran aim at the UNAIDS 90-90-90 targets (UNAIDS 90-90-90 global targets to end the AIDS epidemic by 2020: by 2020, 90% of all people living with HIV will know their HIV status; 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy; and 90% of all people receiving antiretroviral therapy will have viral suppression) and to eliminate mother-to-child HIV transmission. In this article, we discuss the strengths and shortcomings of the current HIV programs and offer suggestions to provide a better perspective to track and respond to the HIV epidemic. More generally, our account of the national religious and cultural circumstances as well as obstacles to the approaches chosen can provide insights for decision-makers in other countries and institutions with comparable settings and infrastructures.
伊朗是中东和北非(MENA)地区的一个国家,在过去的三十年中,一直在积极参与抗击艾滋病毒/艾滋病的斗争。伊朗艾滋病毒流行的独特特征反映在传播模式及其最近为改善管理和预防计划而发生的变化上。在这篇综述中,我们叙述了伊朗艾滋病毒感染的最初发生和随后的传播,从首例诊断病例开始,到目前正在进行的应对措施和控制这一流行的最新成就。虽然在 MENA 地区,伊朗是最早实施包括减少伤害服务在内的相关政策以降低艾滋病毒发病率的国家之一,但药物注射仍然是感染的主要风险。与其他国家一样,伊朗的方案旨在实现联合国艾滋病规划署 90-90-90 目标(联合国艾滋病规划署 90-90-90 全球目标:到 2020 年终结艾滋病流行:到 2020 年,所有艾滋病毒感染者中 90%将知晓其艾滋病毒状况;所有诊断出艾滋病毒感染的人中 90%将接受持续的抗逆转录病毒治疗;所有接受抗逆转录病毒治疗的人中 90%将病毒得到抑制)和消除母婴传播艾滋病毒。在本文中,我们讨论了当前艾滋病毒方案的优缺点,并提出了一些建议,以提供更好的视角来跟踪和应对艾滋病毒流行。更广泛地说,我们对国家宗教和文化环境以及所选择方法的障碍的叙述,可以为其他国家和具有类似环境和基础设施的机构的决策者提供见解。
AIDS. 2021-3-15
Curr HIV Res. 2020
2017-11-3
Int J Drug Policy. 2016-5
HIV AIDS (Auckl). 2025-8-18
Open Forum Infect Dis. 2025-2-4
BMC Public Health. 2024-11-6
Infect Disord Drug Targets. 2020
PLoS One. 2018-11-29